Dystonin (DST) human monoclonal antibody, clone H5E.Hy.4B
Applications | IF, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Dystonin (DST) human monoclonal antibody, clone H5E.Hy.4B
Applications | IF, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Dystonin (DST) human monoclonal antibody, clone H10D-Hy-8B
Applications | IF, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
IL1 alpha (IL1A) human monoclonal antibody, clone HuMab X3
Applications | NEUT |
Reactivities | Human |
Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
CD38 monoclonal antibody (daratumumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
CD70 monoclonal antibody (vorsetuzumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
Conjugation | Unconjugated |
SARS-CoV monoclonal antibody (CR3022 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
Conjugation | Unconjugated |
Recombinant Anti-c-myc epitope tag (Clone 9E10)
Applications | IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-c-myc epitope tag (Clone 9E10)
Applications | IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-c-myc epitope tag (Clone 9E10)
Applications | IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-c-myc epitope tag (Clone 9E10)
Applications | IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
Applications | ELISA, WB |
Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
Applications | ELISA, WB |
Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
Applications | ELISA, WB |
Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
Applications | ELISA, WB |
Conjugation | Unconjugated |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
Conjugation | Unconjugated |
Modifications | This is a chimeric human antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) (Clone B1-8)
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) (Clone B1-8)
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) (Clone B1-8)
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) (Clone B1-8)
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
Applications | ELISA, IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
Applications | ELISA, IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
Applications | ELISA, IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
Applications | ELISA, IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
Conjugation | Unconjugated |
Host | Human |
Isotype | IgG1, kappa |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
Conjugation | Unconjugated |
Host | Human |
Isotype | IgG2, kappa |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
Conjugation | Unconjugated |
Host | Human |
Isotype | IgG3, kappa |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
Conjugation | Unconjugated |
Host | Human |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | FC, IF, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone C225 (Cetuximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-carcinoembryonic antigen (CEA) (Clone Arcitumomab)
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |